Fusion Antibodies PLC Cash Flow Quality Index
Fusion Antibodies PLC cash flow quality index. Fusion Antibodies PLC (FAB) has a Cash Flow Quality Index of -0.31x as of June 2017. Operating cash flow of GBX-9.34K is below net income of GBX29.99K, suggesting accrual-heavy earnings not yet converted to cash. See Fusion Antibodies PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Fusion Antibodies PLC (2016–2017)
Cash flow quality index of Fusion Antibodies PLC from 2016 to 2017. Historical Cash Flow Quality Index for Fusion Antibodies PLC across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore FAB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Fusion Antibodies PLC Cash Flow Quality Index by Year (2016–2017)
Fusion Antibodies PLC cash flow quality index by year from 2016 to 2017. Year-by-year earnings quality comparison for Fusion Antibodies PLC. For the full cash flow conversion analysis, see Fusion Antibodies PLC cash flow conversion.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -0.31x | GBX-37.37K | GBX119.95K | ▼ -203.8% |
| 2016 | 0.30x | GBX346.57K | GBX1.15 Million | — |